Equally, as summarized in Table S1, no statistically significant correlation of SMAD4 expression with age group, gender, KPS, stage of disease at start of palliative chemotherapy, tumor grading and number of metastatic sites was detected using cross tabulations. The gene discussed is SMAD4; the disease is neoplasm.